KRAS突变细胞癌的临床和分子表征
Andrea Lopez Sanmiguel1, Yash S Khandwala1, Kuo Fengshen1,2
1Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Cancers
|December 11, 2025
概括
KRAS突变定义了细胞癌 (RCC) 的不同亚型. 反极性乳头瘤 (PRNRP) 呈现出独特的特征,与激进的KRAS突变乳头瘤和未分类的RCC不同.
科学领域:
- 在瘤学瘤学.
- 生殖尿路病理学
- 分子病理学分子病理学
背景情况:
- KRAS突变在细胞癌 (RCC) 中很少见,主要在逆极性乳头瘤 (PRNRP) 中观察到.
- 对于超出PRNRP的KRAS突变RCC的更广泛的临床病理学和分子特征的理解有限.
研究的目的:
- 描述KRAS突变细胞癌 (RCC) 的临床病理和分子特征.
- 识别和描述KRAS突变RCC中的不同亚型.
主要方法:
- 在MSK-IMPACT和TCGA-KIRP队列中发现了KRAS突变RCC病例.
- 使用FACETS评估拷贝数量的变化;在现有样本上进行了免疫组织化学和RNA测序.
主要成果:
- 确定了三个KRAS突变的RCC亚型:PRNRP (29%),KRAS突变的乳头RCC (PRCC) (35%) 和KRAS突变的未分类RCC (URCC) (35%).
- 在KRAS突变PRCC中,PRNRP表现出远端脏丰富和阳性L1CAM染色,与近端管道丰富和阴性L1CAM形成鲜明对比.
- 在7名患者 (41%) 观察到转移性疾病,仅限于PRCC和URCC亚型,而不是PRNRP.
结论:
- PRNRP是一种独特的KRAS突变RCC亚型,具有独特的基因组和代谢配置文件,起源于远端脏.
- 克拉斯突变PRCC和URCC表现出更大的基因组复杂性和攻击性行为,需要特定亚型的诊断和治疗方法.
更多相关视频
12:22The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
34.1K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.5K
相关概念视频
The Ras Gene
7.0K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.0K
Small GTPases - Ras and Rho
5.1K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
5.1K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
The Retinoblastoma Gene
4.6K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
